HomeSKYE • NASDAQ
Skye Bioscience Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.76M | 91.14% |
Net income | -11.10M | -121.20% |
Net profit margin | — | — |
Earnings per share | -0.28 | -55.56% |
EBITDA | -11.58M | -89.11% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.22M | -29.04% |
Total assets | 64.79M | -31.68% |
Total liabilities | 5.54M | -65.25% |
Total equity | 59.25M | — |
Shares outstanding | 30.98M | — |
Price to book | 1.12 | — |
Return on assets | -42.74% | — |
Return on capital | -45.84% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.10M | -121.20% |
Cash from operations | -9.19M | -95.10% |
Cash from investing | -12.81M | -1,221.66% |
Cash from financing | — | — |
Net change in cash | -21.99M | -126.79% |
Free cash flow | -5.40M | -1,157.76% |
Previous close
$2.14
Day range
$2.13 - $2.21
Year range
$1.14 - $8.99
Market cap
66.31M USD
Avg Volume
221.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2011
Website
Employees
16
